Table 4 Antibodies.

From: FN-EDA mediates angiogenesis of hepatic fibrosis via integrin-VEGFR2 in a CD63 synergetic manner

Antibody

Identifier

Application

FN-EDA

sc-59826, Santa Cruz

WB, IHC, Blocking, IF

FN-EDA

F6140, Sigma

Blocking

CD31

sc-376764, Santa Cruz

WB, IHC, IF

α-SMA

ab5694, Abcam

WB, IHC, IF

CD63

SC5275, Santa Cruz

WB, IHC

CD63

ab134045, Abcam

WB

Albumin

16475-1-AP, Proteintech

IF

pVEGFR2

ab194806, Abcam

WB

pVEGFR2

#2478, CST

WB

VEGFR2

#9698, CST

WB

VEGFR2

26415-1-AP, Proteintech

WB

PI3K p85

ab191606, Abcam

WB

pPI3K p85/p55

ab226842, Abcam

WB

AKT

#4685, CST

WB

pAKT

#4060, CST

WB

PLCγ1

#5640, CST

WB

pPLCγ1

#8713, CST

WB

ERK

#4695, CST

WB

pERK

#4370, CST

WB

Src

#2109, CST

WB

pSrc

#6943, CST

WB

FAK

#3285, CST

WB

pFAK

#3281, CST

WB

integrin β1

26918-1-AP, Proteintech

WB

GAPDH

60004-1-Ig, Proteintech

WB

integrin α9

ab27947, abcam

Blocking

integrin α4

ab25247, Abcam

Blocking

integrin β1

ab24693, Abcam

Blocking

flag

#14793, CST

IP